Atlas Trials

Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia

Clinical trial NCT01712646 · TERMINATED

Trial details

NCT number
NCT01712646
Sponsor
National Institute of Mental Health (NIMH)
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Childhood Onset Psychotic DisordersSchizophrenia
Start date
2012-10-05
Primary completion
2016-06-20
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.